Acute Coronary Syndromes

Acute coronary syndrome (ACS) is most commonly caused by a heart attack (myocardial infarction) where blood flow to the heart is suddenly blocked. This is usually caused by a blood clot from a ruptured coronary artery atherosclerotic plaque. Other causes include spontaneous coronary artery dissection (SCAD), which most commonly occurs in women. ACS is usually treated in a cath lab with angioplasty and the placement of a stent to prop the vessel open.

RSS icon

WHO warns against use of artificial sweeteners, highlighting CVD and diabetes risks

The World Health Organization has published a new guideline recommending against the use of artificial sweeteners such as aspartame and sucralose to lose weight or reduce the risk of noncommunicable diseases.

Thumbnail

How improving access to PCI affects heart attack outcomes

When PCI-capable hospitals open and close, how does it impact patient care for the surrounding area? Researchers aimed to find out, sharing their findings in JACC: Cardiovascular Interventions.

stock market

Avertix Medical, known for its implantable heart attack detection devices, to go public with initial value of $195M

The healthcare technology company, previously known as Angel Medical Systems, is merging with BIOS Acquisition Corporation to form a new publicly traded company.

E-tattoo chest heart monitor designed by engineers with the University of Texas at Austin

A key step forward: Engineers take wearable ‘e-tattoo’ technology for heart disease to the next level

The new-look device, which captures ECG and seismocardiogram measurements at the same time, is completely wireless and runs on batteries that last up to 40 hours. 

Paul M. Ridker, MD, MPH, director of the Center for Cardiovascular Disease Prevention, and the Eugene Braunwald Professor of Medicine, cardiovascular medicine, Brigham and Women's Hospital, who presented the results of late-breaking study on residual inflammatory risk in contemporary statin treated patients. The study used an analyses of 31,197 patients in the PROMINENT, REDUCE-IT and STRENGTH trials. 

What new data can teach cardiologists about statin use and treating inflammation

"If we do not attack the inflammation, we just are not going to get the best outcomes for our patients," one researcher told Cardiovascular Business. 

Janet Wei at Cedars-Sinai Hospital explains INOCA and MINOCA at ACC 2023.

Understanding INOCA and MINOCA epidemiology

Janet Wei, MD, associate medical director of the Biomedical Imaging Research Institute, and co-director of the stress echocardiography lab at Cedars-Sinai Hospital, explains the current information on the INOCA and MINOCA.

New details on the link between CVD and cancer, from a study of 27M patients

According to the large new study, published in JACC: CardioOncology, atherosclerotic CVD is associated with an especially high risk of cancer. 

#ACC23 #ACC #Heartflow

HeartFlow announces US launch of AI-powered solution for evaluating coronary arteries

The AI-powered tool gained FDA clearance back in October 2022. 

Displaying 145 - 152 of 667

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.